Inside an mRNA Melanoma Vaccine Trial: A Patient's View
After cheek melanoma excision in 2023, tennis coach Mark Orwig, 73, joined a global mRNA cancer vaccine trial scientists say could transform treatment.
Topic
Cancer Vaccine
Topic
Cancer Vaccine
Personalized Melanoma Vaccine Holds 49% Recession Reduction at 5 Years
NYU Langone reports a therapeutic cancer vaccine sustained a 49 percent reduction in melanoma recurrence or progression at five y…
mRNA Drug Shows Breakthrough Potential in Deadly Skin Cancer
An experimental mRNA drug has shown breakthrough potential against deadly skin cancer, extending messenger RNA technology from va…
Melanoma Vaccine Candidate Shows Promise: What Dermatologists Know
A personalized mRNA melanoma vaccine cut recurrence or death risk by 44% versus pembrolizumab alone in phase 2b; phase 3 results…
Melanoma Vaccine Cuts Recurrence Risk in Landmark Trial
A landmark trial finds a cancer vaccine prevented deadly melanoma from returning or spreading, a potential turning point in adjuv…
Personalized mRNA Cancer Vaccine Emerges in Melanoma Fight
Individually manufactured mRNA cancer vaccines are entering the melanoma fight, bringing the pandemic-era platform into dermatolo…